Analysis of Costs and Regiment of Cystic Fibrosis Treatment in Adult Patients in Poland

Cystic fibrosis (CF) is a rare disease. Its prevalence in Poland is around 1 : 5000, and adult patients comprise as little as 32% of all patients suffering from this disease. CF treatment is based on a properly selected and effective pharmacotherapy. The aim of this study was to understand the regimen of pharmacotherapy in adult CF population in Poland, and to calculate the costs of drugs used in this group of patients. The researchers conducted a retrospective study. Following an analysis of the patientsí medical documentation, 46 adult patients were included in the study group. Data were sourced from case history forms, doctorsí order sheets and medical treatment records made by physicians. Total pharmacotherapy cost in 2013 amounted to EUR 467876.66 giving EUR 10171.23 (± 2818.39) per patient. The most popular group of drugs used by CF patients was mucolytic drugs, with the estimated cost of EUR 382054.21. Only 14 patients were treated with antibiotics. The total cost of using antibiotics in these 14 patients was estimated at EUR 15393.01. Analysis of the treatment regimen for adult CF patients has shown that treatment regimen of Polish patients differed from the regimen applied in another countries.